These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3279723)

  • 1. Stopping insulin treatment in middle-aged diabetic patients with high postglucagon plasma C-peptide. Effect on glycaemic control, serum lipids and lipoproteins.
    Laakso M; Sarlund H; Korhonen T; Voutilainen E; Majander H; Hakala P; Uusitupa M; Pyörälä K
    Acta Med Scand; 1988; 223(1):61-8. PubMed ID: 3279723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with fasting and postglucagon plasma C-peptide levels in middle-aged insulin-treated diabetic patients.
    Laakso M; Rönnemaa T; Sarlund H; Pyörälä K; Kallio V
    Diabetes Care; 1989 Feb; 12(2):83-8. PubMed ID: 2649329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum lipids and lipoproteins with plasma C-peptide concentration in non-insulin-dependent diabetic and non-diabetic subjects.
    Sarlund H; Laakso M; Pyörälä K; Penttilä I
    Metabolism; 1987 Sep; 36(9):840-5. PubMed ID: 3306277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
    Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
    Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of insulin deficiency among initially non-insulin-dependent middle-aged diabetic individuals.
    Laakso M; Sarlund H; Pyörälä K
    Diabetes Care; 1986; 9(3):228-31. PubMed ID: 3525053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
    Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
    Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins.
    Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.
    Rosenfalck AM; Thorsby P; Kjems L; Birkeland K; Dejgaard A; Hanssen KF; Madsbad S
    Acta Diabetol; 2000 Mar; 37(1):41-6. PubMed ID: 10928235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-C-peptide test as a measure of insulin requirement in type 2 diabetes: evaluation of stopping insulin therapy in eleven patients.
    Viikari J; Rönnemaa T; Koskinen P
    Ann Clin Res; 1987; 19(3):178-82. PubMed ID: 3314647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal and postglucagon C-peptide levels in Ethiopians with diabetes.
    Siraj ES; Reddy SS; Scherbaum WA; Abdulkadir J; Hammel JP; Faiman C
    Diabetes Care; 2002 Mar; 25(3):453-7. PubMed ID: 11874929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse relationship of serum HDL and HDL2 cholesterol to C-peptide level in middle-aged insulin-treated diabetics.
    Laakso M; Voutilainen E; Sarlund H; Aro A; Pyörälä K; Penttilä I
    Metabolism; 1985 Aug; 34(8):715-20. PubMed ID: 3894877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twice daily insulin therapy in patients with type 2 diabetes and secondary failure to sulphonylureas.
    Wolffenbuttel BH; Weber RF; Weeks L; van Koetsveld PM; Verschoor L
    Diabetes Res; 1990 Feb; 13(2):79-84. PubMed ID: 2091874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics.
    Laakso M; Voutilainen E; Sarlund H; Aro A; Pyörälä K; Penttilä I
    Atherosclerosis; 1985 Sep; 56(3):271-81. PubMed ID: 3902037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients.
    Hirano T; Yoshino G; Kashiwazaki K; Adachi M
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):908-13. PubMed ID: 11587157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial amplification of lipoprotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagon levels.
    Cavallero E; Dachet C; Neufcour D; Wirquin E; Mathe D; Jacotot B
    Metabolism; 1994 Mar; 43(3):270-8. PubMed ID: 8139473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM.
    Brussaard HE; Gevers Leuven JA; Frölich M; Kluft C; Krans HM
    Diabetologia; 1997 Jul; 40(7):843-9. PubMed ID: 9243107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients.
    Paolisso G; Sgambato S; Gentile S; Memoli P; Giugliano D; Varricchio M; D'Onofrio F
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1005-10. PubMed ID: 3053747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
    al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
    Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of sensitivity to sulfonylurea after strict glycaemic control with insulin in non-obese type 2 diabetic subjects.
    Torella R; Salvatore T; Cozzolino D; Giunta R; Quatraro A; Giugliano D
    Diabete Metab; 1991; 17(5):443-7. PubMed ID: 1752344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients.
    Juntti-Berggren L; Pigon J; Karpe F; Hamsten A; Gutniak M; Vignati L; Efendic S
    Diabetes Care; 1996 Nov; 19(11):1200-6. PubMed ID: 8908380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.